Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institut Cancerologie de l'Ouest
With
Hospices Civils de Lyon
This is a retrospective study including exhaustively all patients operated CC0-CC1 of peritoneal carcinosis between 2007 and 2019 meeting the inclusion criteria:
* Patients from the Institut de cancérologie de l'Ouest and the CHU of Lyon for the study period 2007-2016
* Patients included in the BIG-RENAPE network between 2016 and 2019
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Age \>18 years
2. Histological evidence of peritoneal metastases
3. Primary colorectal cancer
4. Surgical cytoreduction CC0 or CC1
You may not be if
1. Patient who has not received at least 3 courses of pre and/or post cytoreduction chemotherapy
2. Primitive appendicitis
3. Unknown primitive
4. Patient with incomplete CC2 and/or palliative surgery
5. Patient opposed to the use of their data for research.
6. Isolated local pelvic recurrence.
7. Extraperitoneal metastases not resected or destroyed before or during cytoreduction.
8. Patient opposed to the use of his/her data for research purposes
